Explain pathological effects of massive blood transfusion.

Massive Blood Transfusion

Massive transfusion is not simply "many units of blood". It is the pathology of exsanguination plus replacement therapy. The patient is losing red cells, plasma, platelets, fibrinogen, heat, calcium, acid-base control and endothelial integrity at the same time that transfusion is trying to restore oxygen delivery and haemostasis.

For Primary pathology, the core chain is:

haemorrhage -> hypovolaemic shock -> tissue hypoxia -> acidosis -> endothelial injury and coagulopathy -> more bleeding -> hypothermia/hypocalcaemia from resuscitation -> impaired clotting and myocardial function -> organ failure.

The applied PPH and critical-care algorithms are covered in IntermediatePPH, FinalPPH and Finalobstetric critical care. This chapter teaches why those algorithms exist.

Before any of that makes sense, you need the simplest possible picture of how blood normally stops itself from leaving the vessel. Everything in this chapter is a way that this normal machinery is overwhelmed, diluted, consumed or chemically disabled. So we start there.

How Blood Normally Stops Itself

Start with the healthy vessel. Haemostasis — stopping bleeding — has only two jobs: keep circulating blood inside the vascular bed, and seal any breach quickly without clotting the whole circulation. Four systems do this work, and you can build the entire chapter on these four:

• A normal vessel wall. Intact endothelium is actively anti-thrombotic: it makes prostacyclin and nitric oxide that keep platelets quiet, and it physically hides the clot-triggering layer underneath.
• Platelets in adequate number and function. They form the first plug and supply the phospholipid surface on which the clotting enzymes assemble.
• Coagulation factors — a cascade of inert plasma pro-enzymes that, once triggered, generate thrombin and convert liquid fibrinogen into solid fibrin.
• Fibrinolysis — the controlled demolition system that dissolves clot once it is no longer needed, so we are not slowly cemented solid.

When a vessel is injured, the sequence is mechanical before it is chemical. Platelets stick to exposed collagen, change shape, and release ADP, which recruits more platelets into a soft plug. That plug is fragile. In parallel the coagulation cascade fires, thrombin is generated, and thrombin turns soluble fibrinogen into an insoluble fibrin mesh that laces through the platelets and converts the loose plug into a firm, stable clot. Hold onto that distinction: platelets make the plug, fibrin makes it strong. A patient can have a normal platelet count and still bleed if there is no fibrinogen to firm the clot — which is exactly what happens in obstetric haemorrhage.

The Clotting Cascade in One Pass

You do not need to memorise every factor for Primary, but you must understand the shape, because every coagulation test and every blood product maps onto it.

The single most important point for obstetrics: the placenta and decidua are extraordinarily rich in tissue factor. That is the chapter's central mechanism. When placental tissue, decidua or amniotic fluid enters the maternal circulation — abruption, amniotic fluid embolism, retained products — it dumps a huge tissue-factor load into the blood, firing the extrinsic pathway everywhere at once. That is why obstetric coagulopathy comes on faster and harder than most other bleeding.

Thrombin generation is normally kept local by natural brakes — antithrombin (the target of heparin), and the rapid binding of thrombin to the fibrin it has just made. Lose the localisation and you get coagulation spreading through the whole circulation: the basis of disseminated intravascular coagulation, covered below.

Why Pregnancy Changes the Baseline

Pregnancy is a deliberately hypercoagulable state, engineered to survive the bleeding of placental separation. From early pregnancy, fibrinogen rises until at term it is at least double the non-pregnant level, factors VII, VIII and X rise, and fibrinolysis is actively suppressed (the placenta itself contains fibrinolysis inhibitors). The platelet count drifts down a little — about 10% of well women are below 150 × 10⁹/L at term — but platelet function is preserved.

This matters for two opposite reasons. First, it raises the venous thromboembolism risk that dominates direct maternal mortality in well-resourced settings. Second, and central here, it resets the danger threshold for bleeding: because fibrinogen starts so high, a fibrinogen that looks "normal for a non-pregnant adult" is already dangerously low for a bleeding parturient. A falling or low fibrinogen is one of the earliest and most powerful warnings in PPH.

One last piece of normal physiology explains why the obstetric stakes are so high. At placental separation a blood flow of roughly 500–800 mL/min must be staunched within seconds. The dominant mechanism is not the clotting cascade at all — it is myometrial contraction physically clamping the spiral arteries shut, with the haemostatic system playing a supporting role by sealing the placental bed with fibrin. This is why an atonic uterus bleeds so fast that no transfusion can keep pace, and why source control — getting the uterus to contract — is the central treatment, not an afterthought.

What Massive Haemorrhage Removes

With the normal machinery in mind, massive haemorrhage is now easy to read: it is the simultaneous loss or disabling of all four pillars at once. Whole-blood loss removes every component of circulating physiology.